| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Sep 12, 2025 | Dave Inc./DE | Director | Sell | 27.5 | -4,726 | -5.75% | ✓ | $1.1M |
| Sep 4, 2025 | Sep 5, 2025 | Dave Inc./DE | Director | Sell | 15.0 | -14,660 | -15.15% | ✓ | $2.9M |
| Jun 4, 2025 | Jun 5, 2025 | Dave Inc./DE | Director | Sell | 17.5 | -5,500 | -5.44% | ✗ | $1.1M |
| May 28, 2025 | May 29, 2025 | Core Scientific, Inc./tx | Director | Buy | 100.0 | +110,000 | 30.08% | ✗ | $1.2M |
| Nov 22, 2024 | Nov 22, 2024 | Core Scientific, Inc./tx | Director | Sell | 17.5 | -105,000 | -23.32% | ✗ | $1.9M |
| Mar 15, 2024 | Mar 18, 2024 | Core Scientific, Inc./tx | Director | Buy | 95.0 | +80,000 | 100.00% | ✗ | $246K |
| Mar 7, 2024 | Mar 11, 2024 | Dave Inc./DE | Director | Buy | 68.8 | +800 | 0.84% | ✗ | $29.8K |
| Dec 4, 2023 | Dec 6, 2023 | Dave Inc./DE | Director | Buy | 95.0 | +12,941 | 15.65% | ✗ | $82.8K |
| Mar 13, 2023 | Mar 15, 2023 | ORAMED PHARMACEUTICALS INC. | Director | Buy | 95.0 | +70,000 | 424.24% | ✗ | $141.6K |